Top Markets
Coin of the day
Inventiva S.A. Inventiva S.A.

Inventiva S.A.

IVA
Clasificación en acciones #8990
Inventiva S.A. is a biopharmaceutical firm currently in the clinical... Inventiva S.A. is a biopharmaceutical firm currently in the clinical development phase, specializing in creating orally administered small molecule treatments for conditions such as non-alcoholic steatohepatitis (NASH), mucopolysaccharidoses (MPS), and various other ailments. Their primary drug candidate, Lanifibranor, has successfully concluded Phase IIb clinical trials for the management of NASH. Furthermore, the company is advancing Odiparcil, a compound that has finished Phase IIa clinical testing specifically for treating the MPS VI subtype. Beyond these, Inventiva maintains a development pipeline featuring several early-stage projects targeting oncology and other medical conditions. Strategic partnerships are in place with AbbVie to address autoimmune diseases, and with Boehringer Ingelheim International GmbH for innovating therapies for idiopathic pulmonary fibrosis. Established in 2011, Inventiva S.A. operates from its headquarters in Daix, France.
Precio por acción
$4.74
Última sincronización: 2026-08-28
Capitalización bursátil
$1.12B
Cambio (1 día)
-5.77%
Cambio (1 año)
-16.96%
País
FR
Comercio Inventiva S.A. (IVA)

Categoría

Historial de desdoblamientos de acciones de Inventiva S.A. (IVA)
La acción Inventiva S.A. (símbolo: IVA) tuvo un total de 0 desdoblamientos.
El desdoblamiento más reciente ocurrió el Aug 29, 2026.
Una acción IVA comprada antes de Aug 29, 2026 equivaldría hoy a 0 acciones IVA.
Lista de desdoblamientos de acciones
Año Desdoblamiento Multiplicador Multiplicador acumulado
Not enough data for the provided dates.
Desdoblamientos de acciones de empresas similares o competidoras
Empresa Número de desdoblamientos de acciones Multiplicador acumulado País
1 x2
US
0 -
NL
1 x3
AU
0 -
US
0 -
CH